论文部分内容阅读
目的:探讨“丹参酮ⅡA”联合“血塞通”治疗脑梗死(cerebral infarction,CI)的临床效果。【方法】选取2012年1月～2012年8月入我院治疗的70例脑梗死患者,划分为实验组与对照组。实验组:血塞通注射液400g、丹参酮ⅡA注射液40mg各注入生理盐水250ml内静注,1次/d,治疗14d;对照组:400mg血塞通注射液,加入250ml生理盐水内静注,1次/d,治疗14d;“实验、对照”两组皆行“抗凝”治疗,14d后观察2组疗效。【结果】实验、对照两组疗效评定指标较治疗前:“神经功能缺损水平”与“Fg水平”皆降低,BI水平皆提高。而实验组ESS降低水平、BI上升水平皆优于对照组,差异显著具统计学意义(P<0.05)。结论:“丹参酮ⅡA”联合“血塞通”治疗CI疗效显著,值得临床推广。
Objective: To investigate the clinical effect of “Tanshinone Ⅱ A” combined with “Xuesaitong” in treating cerebral infarction (CI). 【Methods】 Seventy patients with cerebral infarction admitted to our hospital from January 2012 to August 2012 were divided into experimental group and control group. In the experimental group, 400g of Xuesaitong injection and 40mg of tanshinone ⅡA injection were intravenously administered 250ml of normal saline once a day for 14 days. The control group: 400mg Xuesaitong injection, intravenous injection of 250ml of normal saline, 1 / d, treatment 14d; “experiment, control ” two groups are OK “anticoagulant ” treatment, after 14d observed two groups curative effect. [Results] The curative effect of the two groups were lower than those before treatment in both experimental and control groups, and the level of BI increased. In the experimental group, the level of ESS reduction and the level of BI increase were all better than those in the control group, with significant difference (P <0.05). Conclusion: “Tanshinone Ⅱ A” combined with “Xuesaitong” treatment of CI significant effect, worthy of clinical promotion.